Concepedia

Dominik Lobinger

DL

4

Publications

151

Citations

4

H-Index

2018

Active since

Affiliations

Institute of Cytology(Current)

Nottingham Trent University

München Klinik Bogenhausen

Klinikum rechts der Isar

Technical University of Munich

Dominik Lobinger is an author at Institute of Cytology specializing in tumor microenvironment, tumor biology, and immunology.

ORCID

Top concepts

Publications per year

2018–2023

4

Publications

4

Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer

Maxim Shevtsov, Emil Pitkin, A. Ischenko et al. · Frontiers in Immunology · 2019 · 67 citations · Full text

Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients

Dominik Lobinger, Jens Gempt, Wolfgang Sievert et al. · Frontiers in Molecular Biosciences · 2021 · 38 citations · Full text

, , +19

Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition

Stephanie Breuninger, Stefan Stangl, Caroline Werner et al. · Frontiers in Oncology · 2018 · 32 citations · Full text

Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers

Alexia Xanthopoulos, Ann-Kathrin Samt, Christiane Guder et al. · Biomedicines · 2023 · 14 citations · Full text

, , +18

Rows per page

1–4 of 4